Abametapir - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for abametapir and what is the scope of freedom to operate?
Abametapir
is the generic ingredient in one branded drug marketed by Hatchtech and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Abametapir has thirty-six patent family members in fifteen countries.
One supplier is listed for this compound.
Summary for abametapir
International Patents: | 36 |
US Patents: | 2 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 6 |
Patent Applications: | 489 |
What excipients (inactive ingredients) are in abametapir? | abametapir excipients list |
DailyMed Link: | abametapir at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for abametapir
Generic Entry Date for abametapir*:
Constraining patent/regulatory exclusivity:
Dosage:
LOTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for abametapir
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. Reddy's Laboratories Limited | Phase 2 |
Hatchtech Pty Ltd | Phase 2 |
Syneos Health | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for abametapir
US Patents and Regulatory Information for abametapir
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 7,812,163 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 10,292,389 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for abametapir
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 8,212,038 | ⤷ Try for Free |
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 9,839,631 | ⤷ Try for Free |
Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 9,357,783 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for abametapir
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 1169045 | 用於控制體外寄生蟲的方法和組合物 (METHOD AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES) | ⤷ Try for Free |
Denmark | 2457582 | ⤷ Try for Free | |
China | 1822854 | Methods and compositions for controlling ectoparasites | ⤷ Try for Free |
China | 101810613 | Prevention and cure method for ectoparasite and compounds thereof | ⤷ Try for Free |
New Zealand | 544295 | Methods and compositions for controlling ectoparasites using bipyridine derivatives and analogs | ⤷ Try for Free |
Japan | 2007505032 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for Abametapir (Xeglyze)
More… ↓